1-8 of 8
Luigi Dogliotti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A11: Phase II trial of letrozole (L), cyclophosphamide (C) and sorafenib (S) as neoadjuvant therapy in breast cancer patients (BC): Pharmacokinetic (PK) and pharmacodinamic (PD) analysis

Letizia Bazzola, Chiara Foroni, Daniele Andreis, Francesco Ferrozzi, Luigi Dogliotti, Alfredo Berruti, Stephen B. Fox, Adrian L. Harris, Daniele Generali, Alberto Bottini
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A11.
https://doi.org/10.1158/1078-0432.TCME10-A11
Published: 02 February 2016
View article titled, Abstract A11: Phase II trial of letrozole (L), cyclophosphamide (C) and sorafenib (S) as neoadjuvant therapy in breast cancer patients (BC): Pharmacokinetic (PK) and pharmacodinamic (PD) analysis
Journal Articles

Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients

Daniele Generali, Gaynor Bates, Alfredo Berruti, Maria P. Brizzi, Leticia Campo, Simone Bonardi, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Luigi Dogliotti, Alison H. Banham, Adrian L. Harris, Alberto Bottini, Stephen B. Fox
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 1046–1051.
https://doi.org/10.1158/1078-0432.CCR-08-1507
Published: 02 February 2009
View article titled, Immunomodulation of FOXP3<sup>+</sup> Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
Open the PDF for Immunomodulation of FOXP3<sup>+</sup> Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer

Daniele Generali, Stephen B. Fox, Maria Pia Brizzi, Giovanni Allevi, Simone Bonardi, Sergio Aguggini, Manuela Milani, Alessandra Bersiga, Leticia Campo, Rossana Dionisio, Federica Vergoni, Roberto Giardini, Luigi Dogliotti, Alberto Bottini, Adrian L. Harris, Alfredo Berruti
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2673–2680.
https://doi.org/10.1158/1078-0432.CCR-07-1046
Published: 01 May 2008
View article titled, Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer
Open the PDF for Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer in another window
Journal Articles

Thymidylate Synthase Expression in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors

Paolo Ceppi, Marco Volante, Anna Ferrero, Luisella Righi, Ida Rapa, Rosj Rosas, Alfredo Berruti, Luigi Dogliotti, Giorgio V. Scagliotti, Mauro Papotti
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (4): 1059–1064.
https://doi.org/10.1158/1078-0432.CCR-07-1513
Published: 15 February 2008
View article titled, Thymidylate Synthase Expression in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors
Open the PDF for Thymidylate Synthase Expression in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors in another window
Journal Articles

Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer

Daniele Generali, Stephen B. Fox, Alfredo Berruti, John W. Moore, Maria Pia Brizzi, Nilay Patel, Giovanni Allevi, Simone Bonardi, Sergio Aguggini, Alessandra Bersiga, Leticia Campo, Luigi Dogliotti, Alberto Bottini, Adrian L. Harris
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 550–558.
https://doi.org/10.1158/1078-0432.CCR-06-1266
Published: 25 January 2007
View article titled, Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer
Open the PDF for Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer in another window
Journal Articles

Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

Daniele Generali, Alfredo Berruti, Maria P. Brizzi, Leticia Campo, Simone Bonardi, Simon Wigfield, Alessandra Bersiga, Giovanni Allevi, Manuela Milani, Sergio Aguggini, Valeria Gandolfi, Luigi Dogliotti, Alberto Bottini, Adrian L. Harris, Stephen B. Fox
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4562–4568.
https://doi.org/10.1158/1078-0432.CCR-05-2690
Published: 09 August 2006
View article titled, Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer
Open the PDF for Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer in another window
Journal Articles

Changes in Microvessel Density As Assessed by CD34 Antibodies after Primary Chemotherapy in Human Breast Cancer

Alberto Bottini, Alfredo Berruti, Alessandra Bersiga, Maria Pia Brizzi, Giovanni Allevi, Giovanna Bolsi, Sergio Aguggini, Antonio Brunelli, Enrico Betri, Daniele Generali, Lorena Scaratti, Giovanni Bertoli, Palmiro Alquati, Luigi Dogliotti
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1816–1821.
Published: 01 June 2002
View article titled, Changes in Microvessel Density As Assessed by CD34 Antibodies after Primary Chemotherapy in Human Breast Cancer
Open the PDF for Changes in Microvessel Density As Assessed by CD34 Antibodies after Primary Chemotherapy in Human Breast Cancer in another window
Journal Articles

p53 but not bcl-2 Immunostaining Is Predictive of Poor Clinical Complete Response to Primary Chemotherapy in Breast Cancer Patients

Alberto Bottini, Alfredo Berruti, Alessandra Bersiga, Maria Pia Brizzi, Antonio Brunelli, Gabriella Gorzegno, Bianca DiMarco, Sergio Aguggini, Giovanna Bolsi, Fernando Cirillo, Luciano Filippini, Enrico Betri, Giovanni Bertoli, Palmiro Alquati, Luigi Dogliotti
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2751–2758.
Published: 01 July 2000
View article titled, p53 but not bcl-2 Immunostaining Is Predictive of Poor Clinical Complete Response to Primary Chemotherapy in Breast Cancer Patients
Open the PDF for p53 but not bcl-2 Immunostaining Is Predictive of Poor Clinical Complete Response to Primary Chemotherapy in Breast Cancer Patients in another window